Tuesday, January 12, 2010

A False Pandemic or a Global Fraud?

NOW, THEREFORE, I, BARACK OBAMA, President of the United States of America, by virtue of the authority vested in me by the Constitution and the laws of the United States, do hereby proclaim the week of January 10-16, 2010, as National Influenza Vaccination Week. I encourage all Americans to observe this week by getting the H1N1 flu vaccine if they have not yet done so, and by asking their families, friends, and co-workers to do the same.
- Presidential Proclamation dated January 9, 2010

If this is National Influenza Vaccination Week, you've got to be wondering why Reuters is reporting today that "the World Health Organization is to examine its handling of the H1N1 pandemic, the group said on Tuesday, after accusations by some politicians that it exaggerated the dangers of the virus under pressure from drug companies."

THE SMALL PRINT in the story: There is no timeline for the examination and WHO won't say what experts will be involved. But, "goverments" will be asking tough questions, according to Reuters.

MISSING ALTOGETHER
Missing from the Reuters story is a link to this from Australia. "Swine flu 'a false pandemic' to sell vaccines, expert says". The expert is Wolfgang Wodarg, head of health at the Council of Europe. link. Wodarg has charged "that a group of people in the WHO is associated very closely with the pharmaceutical industry and that millions of people have been vaccinated with products with inherent possible health risks." And outrageous costs. (Wodarg's blog. Read his interview with a Danish publication.)

How costly?
Germany spent about 700million Euros on the World Health Organization-declared pandemic, but they may have spent more.
"But it is very difficult to know the exact figures because we are talking about vaccines resold to foreign countries, and most firms do not communicate due to the principles of 'trade secrets'."
The British government is "desperately trying to offload up to £1billion of swine flu vaccine, ordered at the height of the scare" and they aren't alone.
The Netherlands, Spain, France and Germany are among those that have publicly acknowledged they are looking to either sell excess vaccine or scale back their orders. And Australia has admitted it has used only about one-quarter of the doses it purchased.

The Netherlands has already sold surplus doses. And in recent days, France has announced it is cancelling more than half of its original order of 94 million doses. Reports suggest France is also negotiating to sell vaccine to countries in the Middle East and Central America.
In fact, France ordered 869 million euros worth of the vaccines. After cancelling the order, they are expected to "save" 350 million euros. To date, an estimated 198 people died of the virus in France.

In January 2010, Canada got rid of her excess when she lent offloaded five million doses of the vaccine to Mexico. But even before that, the United States, Australia, Brazil, France, Italy, New Zealand, Norway, Switzerland and the United Kingdom all indicated in September that they would contribute vaccine to WHO for distribution.

GENEROSITY OR CALCULATED SELF-INTEREST?
Why so generous? Because by September 2009 they knew the pandemic was not genuine. They had been suckered when WHO declared H1N1 a pandemic with a Level 6 alert level in June 2009. In his interview, Wodarg said he found it suspicious that WHO changed it’s definition of a pandemic on it’s homepage at the end of May this year so that by June 2009 it was no longer necessary, that "an enormous amount of people have contracted the illness or died” - there simply have to be a virus, spreading beyond borders, and one that people have no immunity towards,” to constitute a pandemic.

In August 2009, Dr. Wodarg raised concerns about serious reactions to the vaccine, cancer cells used to produce the vaccine and the "orchestration" of people's fears.

September 2009
While public debate was raging in Europe, Public Health Care workers in New York City were ordered to take the vaccine or lose their jobs. They flatly refused and took their case to court where they got an injunction. The mandate was rescinded in October. (The press release claimed they rescinded the order because the vaccines were in short supply and "so that the limited vaccine supplies can be used for populations most at risk of serious illness and death .")

October 2009
The Guardian was reporting that Baxter, Deerfield, Illinois, pharmaceutical company whose Celvapan H1N1 was given approval by the European Medicines Agency was awarded a contract to produce 132 million doses of vaccine for Britain despite the company having paid out millions in out-of-court settlements to Texas, Alabama, California, Hawaii, Alaska, Kentucky, Illinois and Wisconsin after being accused of fraud amid allegations that it had overpriced medicines by as much as 1,300%.

By now, the German Army refused to give the Baxter vaccine with additives that were ordered to be included by the World Health Organization in July. (It's hard not to come to the conculsion that the additives were ordered to qualify Celvapan for the European contract. Not inconsequential was that Celvapan required TWO doses, not one.) Backlash began against WHO.

Spiegel Online was blunt about the World Health Organization's advisors.
"WHO’s vaccine advisory panel is stacked executives from Baxter, Novartis, GSK and Sanofi. Baxter’s own scientists have stated in the New England Journal of Medicine that adjuvants do not improve antibody response.
By the end of 2009, Ireland cancelled orders for Baxter's "untested" Celvapan.

Baxter's controversial record isn't limited to overcharging. See Controversies

February 2009. Baxter International’s research facility in Orth-Donau, Austria, released a contaminated virus material to an Austrian research company. The Austrian firm, Avir Green Hills Biotechnology, then sent portions of it to sub-contractors in the Czech Republic, Slovenia and Germany.
The contamination incident, which is being investigated by the four European countries, came to light when the subcontractor in the Czech Republic inoculated ferrets with the product and they died. Ferrets shouldn’t die from exposure to human H3N2 flu viruses.

Public health authorities concerned about what has been described as a “serious error” on Baxter’s part have assumed the death of the ferrets meant the H5N1 virus in the product was live.
Baxter stonewalled investigators until forced to admit the virus was live. Worse, it was a mix of mix of H3N2 seasonal flu viruses and unlabelled H5N1 viruses.
Accidental release of a mixture of live H5N1 and H3N2 viruses could have resulted in dire consequences.

While H5N1 doesn’t easily infect people, H3N2 viruses do. If someone exposed to a mixture of the two had been simultaneously infected with both strains, he or she could have served as an incubator for a hybrid virus able to transmit easily to and among people.
Eight months later after that disaster, Baxter got approval from the European Commission for their CELVAPAN H1N1 pandemic vaccine.

THINK how much easier and cheaper it will be when pharmaceutical companies like Baxter can get away with inflating prices 1300% for medicaid. It won't be 50 Attorney Generals investigating them. Just one - at the federal level. Pharmas can afford to buy off one AG, just not 50.

RESOURCES
Text of Resolution to investigate
Europe to Investigate the UN over ‘Pandemic’ Scam
In addition to the "global warming" rip off, you can add another huge international racketeering operation – the H1N1 "pandemic" of 2009.

No comments:

Post a Comment